Clinical Trials
4 trialsNCT04373265 2024-02-23
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Corcept Therapeutics
Phase 1 Completed
NCT00585637 2015-04-01
Vitamin D for Chemoprevention
Dana-Farber Cancer Institute
Phase 1 Completed
NCT01599143 2012-05-15
mbsr
North York General Hospital
Phase 1 Completed
NCT00242645 2010-08-25
Computer-Assisted Cancer Risk Behavior Counseling
Thomas Jefferson University
Phase 1 Terminated